Ad is loading...
BRNS
Price
$0.97
Change
-$0.41 (-29.71%)
Updated
Nov 15 closing price
124 days until earnings call
SLNO
Price
$51.80
Change
-$2.28 (-4.22%)
Updated
Nov 15 closing price
128 days until earnings call
Ad is loading...

BRNS vs SLNO

Header iconBRNS vs SLNO Comparison
Open Charts BRNS vs SLNOBanner chart's image
Barinthus Biotherapeutics
Price$0.97
Change-$0.41 (-29.71%)
Volume$263.3K
CapitalizationN/A
Soleno Therapeutics
Price$51.80
Change-$2.28 (-4.22%)
Volume$656.86K
CapitalizationN/A
BRNS vs SLNO Comparison Chart
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BRNS vs. SLNO commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a StrongSell and SLNO is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BRNS: $0.97 vs. SLNO: $51.80)
Brand notoriety: BRNS and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 681% vs. SLNO: 103%
Market capitalization -- BRNS: $39.03M vs. SLNO: $2.23B
BRNS [@Biotechnology] is valued at $39.03M. SLNO’s [@Biotechnology] market capitalization is $2.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, BRNS is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 4 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • BRNS’s TA Score: 4 bullish, 5 bearish.
  • SLNO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BRNS and SLNO are a bad buy in the short-term.

Price Growth

BRNS (@Biotechnology) experienced а -28.13% price change this week, while SLNO (@Biotechnology) price change was -9.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BRNS is expected to report earnings on Mar 21, 2025.

SLNO is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($2.23B) has a higher market cap than BRNS($39M). SLNO YTD gains are higher at: 28.696 vs. BRNS (-73.707). BRNS has higher annual earnings (EBITDA): -59.49M vs. SLNO (-66.53M). SLNO has more cash in the bank: 266M vs. BRNS (118M). SLNO has less debt than BRNS: SLNO (296K) vs BRNS (12.6M). BRNS (0) and SLNO (0) have equivalent revenues.
BRNSSLNOBRNS / SLNO
Capitalization39M2.23B2%
EBITDA-59.49M-66.53M89%
Gain YTD-73.70728.696-257%
P/E RatioN/AN/A-
Revenue00-
Total Cash118M266M44%
Total Debt12.6M296K4,257%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRNSSLNO
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BOSYX22.02-0.22
-0.99%
BNY Mellon Sm Cp Val Y
MGGLX34.89-0.41
-1.16%
Morgan Stanley Inst Global Opp L
WFSPX688.63-9.11
-1.31%
iShares S&P 500 Index K
LMTIX25.04-0.38
-1.49%
Franklin U.S. Large Cap Equity I
UOPSX75.14-3.79
-4.80%
ProFunds UltraNASDAQ-100 Svc

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-29.70%
SLNO - BRNS
56%
Loosely correlated
-4.22%
NGNE - BRNS
51%
Loosely correlated
-11.95%
BNOX - BRNS
50%
Loosely correlated
-8.11%
IMVT - BRNS
48%
Loosely correlated
-5.06%
TARA - BRNS
35%
Loosely correlated
-4.26%
More